PANACEABIO — Panacea Biotec Cashflow Statement
0.000.00%
Last trade - 00:00
- IN₹8.35bn
- IN₹6.69bn
- IN₹4.60bn
- 40
- 36
- 38
- 27
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 486 | -1,712 | -1,442 | 14,488 | 128 |
Depreciation | |||||
Non-Cash Items | -1,283 | 2,030 | 1,839 | -14,987 | -1,350 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 1,291 | -1,062 | 209 | -1,022 | -3,394 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,045 | -302 | 1,067 | -1,084 | -4,225 |
Capital Expenditures | -47.8 | -69.1 | -218 | -125 | -409 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -5.69 | -278 | -259 | 12,951 | 4,713 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -53.5 | -348 | -477 | 12,826 | 4,303 |
Financing Cash Flow Items | -664 | -451 | -994 | -3,898 | -36 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,011 | 907 | -471 | -11,759 | -184 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -19.7 | 258 | 119 | -17.3 | -105 |